August 7, 2012 - Theorem Clinical Research and Gallus BioPharmaceuticals Announce an Exclusive Partnership to Help Companies Accelerate Their Research, Development and Manufacturing of Biopharmaceuticals
June 23-26, 2013 - European Society for Animal Cell Technology - Lille, France
July 1-2, 2013 - World Biopharm Forum - Robinson College Cambridge, UK
Sep 16-19, 2013 - BioProcess International - Hynes Convention Center, Boston, MA
Sep 17-19, 2013 - Annual BioPharm America - Westin Boston Waterfront, Boston, MA
Oct 22-24, 2013 - CPHI/ICSE - Messe Frankfurt, Germany
Nov 3-6, 2013 - ISPE, Annual Meeting - Hynes Convention Center, Washington, DC
Nov 4-6, 2013 - BIO-Europe 2013 - Westin Boston Waterfront - Vienna, Austria
Nov 18-19, 2013 - Annual Bio-Development Global Congress - Boston, MA
Welcome to Gallus BioPharmaceuticals
Gallus BioPharmaceuticals delivers end-to-end biologics process development and cGMP drug manufacturing for pre-clinical, clinical and commercial stages for pharmaceutical, biotechnology and government organizations.
Unlike conventional contract manufactures, we empower you – our customers – by accelerating your time to market through personal symbiotic collaboration and virtual ownership models driven by advanced single-use technologies. Our sweeping approval from every major regulatory body across the globe, including the FDA, EMA, HealthCanada, ANVISA and PMDA, ultimately makes us the ideal partner for your entire suite of contract manufacturing needs.
Discover your own SuiteSPACE™
SuiteSPACE™ is Gallus's unique virtual ownership solution, designed to empower your drug manufacturing and mammalian cell culture processes. Supported by our experienced scientific team, SuiteSPACE™ captures the feeling of having your own facility while providing the flexibility you crave. The facility is specially tailored to meet and more easily adapt to your project’s specific needs. For more information, Contact Us.